Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Pluton Biosciences, a St. Louis-Based Biotech Start-Up, Discovers New Ways to Stop Zika Virus
Pluton Biosciences Files for Patent on First Discovery.
(July 12, 2018)

ST. LOUIS, July 12, 2018 /PRNewswire-PRWeb/ -- PLUTON BIOSCIENCES FILES FOR PATENT ON FIRST DISCOVERY

Each year, mosquitoes kill approximately 725,000 people by spreading blood-borne disease and viruses.

And one species, the Aedes aegypti mosquito, has been notably destructive. Aedes is a vector for dengue and yellow fever, Chikungunya, and the Zika virus, which emerged in 2015 causing birth defects in children of mothers who carry the virus.



For many companies, a cure would involve treating the disease only after a person has been infected.

But for Pluton Biosciences, a St. Louis-based biotech start-up, a cure means stopping the diseases before they start.

Using its industry disrupting Micromining™ process, in just three months time Pluton Biosciences was able to identify two novel bacterial solutions to kill the Aedes larvae, opening a new path to explore in mosquito vector control. Pluton filed to patent these new biopesticides in April 2018.

How is finding a solution in three months possible?

Pluton uses its proprietary Micromining™ platform to "mine" billions of microbes from a collection of diverse soil samples. By fusing classic microbiology assay design to automation, image capture techniques, and computational biology, Micromining™ quickly and inexpensively isolates microbes with novel modes of action 100 times faster than current leading research labs.

But Pluton Biosciences is more than just a research company.

By partnering with manufacturers to create natural bioproducts for the pesticide, agriculture, pharmaceutical, and bioremediation industries, Pluton Biosciences aspires to solve global problems and helps ensure a sustainable future for our planet.

Pluton Biosciences can be reached by calling (314) 575-8355, emailing [email protected], or visiting plutonbio.com.

Pluton Biosciences, building a sustainable tomorrow by Micromining Nature's Solutions™ today.

 

SOURCE PRWeb House E-Commerce

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Disease,Surgery,Science,Lifestyle,Medical,Biology,Children,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Robotics Prosthetics Market Exclusive Analysis by MRFR | Industry Growing with 9.5% CAGR up to 2027 | The Demand for Robotic Prosthetic is Found to be Increasing across the Globe
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines